GGrantIndex
Sort

21,281 grants matching influenza

Prostate Cancer Immunotherapy

$693,642
Robert B Darnell · Rockefeller University · R01 · FY2006 · CA

TCR repertoire: size, diversity, and function

$693,547
Nan-Ping Weng · National Institute On Aging · ZIA · FY2021 · AG

Programming Durable Immune Responses To Vaccination

$693,502
Ali Hassan Ellebedy · Washington University · U01 · FY2020 · AI

Nanoparticle Vaccine Production Core

$693,085
Jenny P.y. Ting · Univ Of North Carolina Chapel Hill · U19 · FY2014 · AI

Sphingolipid signaling in the endothelium during viral host defense

$692,976
Timothy Tun Hla · Boston Children'S Hospital · R01 · FY2025 · HL

Conjugate vaccines for prevention and treatment of cryptococcosis

$692,433
Arturo Casadevall · Johns Hopkins University · R01 · FY2022 · AI

Conjugate vaccines for prevention and treatment of cryptococcosis

$692,433
Arturo Casadevall · Johns Hopkins University · R01 · FY2024 · AI

Conjugate vaccines for prevention and treatment of cryptococcosis

$692,433
Arturo Casadevall · Johns Hopkins University · R01 · FY2023 · AI

Influenza Viral Pathogenesis

$692,395
Jeffery Taubenberger · Niaid Extramural Activities · Z01 · FY2007 · AI

Safety Studies for Clinical Trials of a Botanical Drug for Sickle Cell Disease

$692,340
Robert Swift · Invenux, Llc · R44 · FY2017 · HL

Molecular Determinants of Human Pathogenic Bunyavirus Virulence and Evolution

$692,229
Hideki Ebihara · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI

Hospital and Household Studies of Respiratory Cryptosporidiosis and Transmission

$692,202
Jeffrey K Griffiths · Tufts University Boston · R01 · FY2014 · AI

De Novo Design of Minibinder Antagonists for COVID-19 and Future Pandemics

$692,102
David Baker · University Of Washington · R01 · FY2024 · AI

Combination Adjuvants to Activate Human Dendritic Cell Subsets and B Cells

$692,040
Jacques F Banchereau · Jackson Laboratory · U01 · FY2016 · AI

High-throughput assays and small-molecule discovery of antiviral candidates targeting influenza hemagglutinin

$691,905
Ian A Wilson · Scripps Research Institute, The · R01 · FY2024 · AI

Centralized IIS-Based Reminder-Recall to Increase Influenza Vaccination Rates

$691,887
Allison Kempe · University Of Colorado Denver · R01 · FY2016 · AI

ETS-family Transcription Factor Mediated Control of Pulmonary Inflammation Induced by Influenza Viruses

$691,840
Nicholas S Heaton · Duke University · R01 · FY2025 · AI

Immunomodulation for Heart Allograft Tolerance

$691,434
Richard N Pierson · University Of Maryland Baltimore · U01 · FY2010 · AI

Prostate Cancer Immunotherapy

$691,169
Robert B Darnell · Rockefeller University · R01 · FY2007 · CA

PROmotion of COVid-19 VA(X)ccination in the Emergency Department - PROCOVAXED

$691,073
Robert Rodriguez · University Of California, San Francisco · R01 · FY2022 · AI

Design and Analysis of Vaccine Trials for Emerging Infectious Disease Threats

$690,994
Natalie Exner Dean · Emory University · R01 · FY2022 · AI

Characterizing persistent subclinical neurobehavioral effects of COVID-19 in a diverse urban population

$690,928
Johanna Patricia Daily · Albert Einstein College Of Medicine · R01 · FY2023 · NS

Prdm3/16 Regulate Chromatin Accessibility to Determine Alveolar Maturation

$690,923
Jeffrey A Whitsett · Cincinnati Childrens Hosp Med Ctr · R01 · FY2024 · HL

Type 2 Inflammation and Remodeling Elicited Through an LTE4/OXGR1-dependent pathway

$690,810
Nora Amanda Barrett · Brigham And Women'S Hospital · R01 · FY2025 · AI

Dynamics of Influenza Transmission in Nicaraguan Households

$690,493
Aubree L Gordon · University Of Michigan At Ann Arbor · R01 · FY2018 · AI